The efficacy of retreatment with the same medication for early treatment failure of bacterial vaginosis

Sex Transm Dis. 2009 Nov;36(11):711-3. doi: 10.1097/OLQ.0b013e3181af6cfd.

Abstract

Few data exist regarding management strategies for women with early treatment failure for bacterial vaginosis. Cure rates after re-treatment were compared for two topical agents. The overall cure rate was 62%; rates between medications were comparable. Re-treatment with the same topical medication for early recurrence is an acceptable strategy.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Adult
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Clindamycin / administration & dosage
  • Clindamycin / therapeutic use*
  • Cohort Studies
  • Drug Administration Schedule
  • Female
  • Humans
  • Metronidazole / administration & dosage
  • Metronidazole / therapeutic use*
  • Recurrence
  • Treatment Failure
  • Treatment Outcome
  • Vaginosis, Bacterial / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Metronidazole
  • Clindamycin